Clinical-stage biotech company TScan Therapeutics Inc. (TCRX) is emerging as an interesting biotech name to watch, with fresh momentum across both its autoimmune and oncology programs.
Company Overview
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com